Found: 10
Select item for more details and to access through your institution.
Using HScore for Evaluation of Hemophagocytosis in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children.
- Published in:
- Biomedicines, 2024, v. 12, n. 2, p. 294, doi. 10.3390/biomedicines12020294
- By:
- Publication type:
- Article
Determination of Risk Factors for Severe Life-Threatening Course of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children.
- Published in:
- Children, 2023, v. 10, n. 8, p. 1366, doi. 10.3390/children10081366
- By:
- Publication type:
- Article
COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report.
- Published in:
- Biomedicines, 2023, v. 11, n. 3, p. 870, doi. 10.3390/biomedicines11030870
- By:
- Publication type:
- Article
Juvenile idiopathic arthritis patients with positive family history of autoimmune thyroid disease might benefit from serological screening: analysis of the international Pharmachild registry.
- Published in:
- Pediatric Rheumatology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12969-023-00802-1
- By:
- Publication type:
- Article
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
- By:
- Publication type:
- Article
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
- By:
- Publication type:
- Article
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
- By:
- Publication type:
- Article
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
- By:
- Publication type:
- Article
Failure of tocilizumab treatment in a CINCA patient: clinical and pathogenic implications.
- Published in:
- Rheumatology, 2013, v. 52, n. 9, p. 1731, doi. 10.1093/rheumatology/ket121
- By:
- Publication type:
- Article
Failure of tocilizumab treatment in a CINCA patient: clinical and pathogenic implications.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article